Vertex Pharmaceuticals reported $126.9M in Trade Creditors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 10.01M 1.85M
Agios Pharmaceuticals AGIO:US USD 10.42M 2.62M
Alnylam Pharmaceuticals ALNY:US USD 40.57M 11.85M
Amgen AMGN:US USD 1.2B 52M
Arrowhead Research ARWR:US USD 2.87M 3.03M
Biogen BIIB:US USD 383.2M 51.6M
Bluebird Bio BLUE:US USD 18.62M 6.24M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Insmed INSM:US USD 11.58M 19.57M
Intercept Pharmaceuticals ICPT:US USD 21.3M 9.64M
IONIS PHARMACEUT IONS:US USD 20.54M 10.19M
Moderna Inc MRNA:US USD 330M 149M
Novartis NOVN:VX USD 4.69B 276M
Ptc Therapeutics PTCT:US USD 20.86M 2.02M
Puma Biotechnology PBYI:US USD 14.93M 5.09M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M
Sangamo Biosciences SGMO:US USD 17.38M 4.3M
Sarepta Therapeutics SRPT:US USD 118.46M 62.25M
Seattle Genetics SGEN:US USD 144.5M 15.63M
Ultragenyx Pharmaceutical RARE:US USD 23.53M 10.68M
Vertex Pharmaceuticals VRTX:US USD 126.9M 71.1M
YTE INCY:US USD 163.17M 31.6M